Radiesse® Dermal Filler Informed Consent


Following your Radiesse® treatment, please review the information below to understand the procedure, potential risks, and your responsibilities as a patient.


Procedure Description

Radiesse® is an FDA-approved injectable dermal filler composed of calcium hydroxylapatite (CaHA) microspheres suspended in a gel carrier. It is used to restore volume, improve facial contours, soften wrinkles and folds, and stimulate collagen production.


Radiesse may be injected into areas including but not limited to:

Results are temporary and typically last 9–18 months, though duration varies depending on the treatment area, metabolism, and lifestyle factors.

No guarantee has been made regarding the outcome of this procedure.



Off-Label Use

I understand that certain treatment areas or techniques may be off-label, meaning they are not specifically included in FDA labeling but are commonly performed in aesthetic medicine based on clinical experience and medical literature.


Potential Benefits

Benefits may include improved facial volume and contour, reduction in wrinkles and folds, collagen stimulation and skin quality improvement, and non-surgical treatment with minimal downtime.

Individual results vary.


Common Side Effects

Temporary side effects may occur and usually resolve within several days to two weeks, including swelling, bruising, redness, tenderness, itching, firmness or palpable product, and mild asymmetry.



Possible Complications

Although uncommon, the following complications may occur:

Radiesse cannot be dissolved like hyaluronic acid fillers and may require medical management if complications occur.


Rare but Serious Risks

Although rare, injectable fillers carry a risk of vascular occlusion, which occurs when filler blocks a blood vessel. Possible consequences may include skin necrosis (tissue death), scarring, vision changes, partial or permanent blindness, and stroke.

These complications are medical emergencies and require immediate treatment.